Crossmark

The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s00198-020-05638-z

Published Online: 2020-10-08

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rønn, S.H.

Harsløf, T.

Oei, L.

Pedersen, S.B.

Langdahl, B.L. https://orcid.org/0000-0002-8712-7199
Funding

Funding for this research was provided by:

Aase og Ejnar Danielsens Fond

Danish Osteoporosis Society

Familien Hede Nielsens Fond

Orkla Health

Region Midtjylland
License Information

Text and Data Mining valid from 2020-10-08

Version of Record valid from 2020-10-08
More Information

Article History

Received: 29 May 2020

Accepted: 11 September 2020

First Online: 8 October 2020

Compliance with ethical standards

:

: SHR, LO and SBP have nothing to disclose. TH has received honoraria for lectures from Amgen and Eli Lilly. BL has received research funding from Novo Nordisk and Amgen and has received honoraria for lectures and advisory boards from Amgen, UCB, Eli Lilly, Gilead, and Gedeon-Richter.

Document is current

Any future updates will be listed below